Artikel
Flat-of-the-curve medicine: A new perspective on the production of health
Health economists have studied the determinants of the expected value of health status as a function of medical and non-medical inputs, often finding small marginal effects of the former. However, medical inputs may have an additional benefit in the form of a reduced variability of health status. Using the standard deviation of life expectancy in 24 OECD countries between 1960 and 2005, a 10 percent increase of health care expenditure is associated with a decrease of an estimated 0.42 percent. Willingness to pay for such a reduction of uncertainty may well exceed the extra health care expenditure in the United States and Switzerland. This implies that even in these two countries with very high health care expenditure per capita, flat-of-the-curve medicine need not be wasteful.
- Sprache
-
Englisch
- Erschienen in
-
Journal: Health Economics Review ; ISSN: 2191-1991 ; Volume: 1 ; Year: 2011 ; Issue: 2 ; Pages: 1-10 ; Heidelberg: Springer
- Klassifikation
-
Wirtschaft
- Thema
-
production of health
control over health status
willingness to pay
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Schoder, Johannes
Zweifel, Peter
- Ereignis
-
Veröffentlichung
- (wer)
-
Springer
- (wo)
-
Heidelberg
- (wann)
-
2011
- DOI
-
doi:10.1186/2191-1991-1-2
- Handle
- Letzte Aktualisierung
-
20.09.2024, 08:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Artikel
Beteiligte
- Schoder, Johannes
- Zweifel, Peter
- Springer
Entstanden
- 2011
Ähnliche Objekte (12)
Nachlaßakte Peter Zweifel
Identifizierung kommt vor Optimierung: Eine Kritik neuerer Entwicklungen in der mikroökonomischen Theorie
Managed Care: Prescription for Failure? Lessons from Switzerland
Buying efficiency: optimal hospital payment in the presence of double upcoding
The purpose and limits of social health insurance
The Structure of Technology, Federal Republic of Germany, 1950-1973: Comment
Solvency regulation: An assessment of Basel III for banks and of planned Solvency III for insurers
Flat-of-the-curve medicine: A new perspective on the production of health
Is the welfare state sustainable? Experimental evidence on citizens' preferences for redistribution
Why Does Income Redistribution Differ Between Countries? Comparative Evidence From Germany and Switzerland
The Contribution of Managed Care to the Performance of Healthcare Systems - Evidence from Three Countries
Willingness-to-pay against dementia: Effects of altruism between patients and their spouse caregivers
Nachlaßakte Peter Zweifel
Identifizierung kommt vor Optimierung: Eine Kritik neuerer Entwicklungen in der mikroökonomischen Theorie
Managed Care: Prescription for Failure? Lessons from Switzerland
Buying efficiency: optimal hospital payment in the presence of double upcoding
The purpose and limits of social health insurance
The Structure of Technology, Federal Republic of Germany, 1950-1973: Comment
Solvency regulation: An assessment of Basel III for banks and of planned Solvency III for insurers
Flat-of-the-curve medicine: A new perspective on the production of health
Is the welfare state sustainable? Experimental evidence on citizens' preferences for redistribution
Why Does Income Redistribution Differ Between Countries? Comparative Evidence From Germany and Switzerland
The Contribution of Managed Care to the Performance of Healthcare Systems - Evidence from Three Countries
Willingness-to-pay against dementia: Effects of altruism between patients and their spouse caregivers
Nachlaßakte Peter Zweifel
Identifizierung kommt vor Optimierung: Eine Kritik neuerer Entwicklungen in der mikroökonomischen Theorie
Managed Care: Prescription for Failure? Lessons from Switzerland
Buying efficiency: optimal hospital payment in the presence of double upcoding
The purpose and limits of social health insurance
The Structure of Technology, Federal Republic of Germany, 1950-1973: Comment
Solvency regulation: An assessment of Basel III for banks and of planned Solvency III for insurers
Flat-of-the-curve medicine: A new perspective on the production of health
Is the welfare state sustainable? Experimental evidence on citizens' preferences for redistribution
Why Does Income Redistribution Differ Between Countries? Comparative Evidence From Germany and Switzerland
The Contribution of Managed Care to the Performance of Healthcare Systems - Evidence from Three Countries